Elizabeth Arden Receives Consensus Recommendation of “Hold” from Analysts (NASDAQ:RDEN)
Elizabeth Arden (NASDAQ:RDEN) has earned a consensus rating of “Hold” from the seven analysts that are currently covering the stock, AnalystRatingsNetwork reports. Five equities research analysts have rated the stock with a hold rating, The average 12-month target price among analysts that have covered the stock in the last year is $25.20.
Elizabeth Arden (NASDAQ:RDEN) opened at 16.92 on Wednesday. Elizabeth Arden has a 52 week low of $14.65 and a 52 week high of $40.40. The stock has a 50-day moving average of $20.32 and a 200-day moving average of $26.56. The company’s market cap is $503.4 million.
Elizabeth Arden (NASDAQ:RDEN) last issued its quarterly earnings data on Tuesday, August 19th. The company reported ($1.04) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.34) by $0.70. The company had revenue of $191.72 million for the quarter, compared to the consensus estimate of $241.64 million. During the same quarter last year, the company posted $0.10 earnings per share. Elizabeth Arden’s revenue was down 28.4% compared to the same quarter last year. On average, analysts predict that Elizabeth Arden will post $-0.41 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at B. Riley cut their price target on shares of Elizabeth Arden from $23.00 to $17.00 in a research note on Wednesday. They now have a “neutral” rating on the stock. Analysts at SunTrust downgraded shares of Elizabeth Arden from a “buy” rating to a “neutral” rating in a research note on Tuesday, August 19th. They now have a $15.00 price target on the stock, down previously from $35.00.
Elizabeth Arden, Inc is a beauty products company with a range of portfolio of fragrance, skin care and cosmetics brands.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.